These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The endocannabinoids anandamide and virodhamine modulate the activity of the candidate cannabinoid receptor GPR55. Sharir H; Console-Bram L; Mundy C; Popoff SN; Kapur A; Abood ME J Neuroimmune Pharmacol; 2012 Dec; 7(4):856-65. PubMed ID: 22454039 [TBL] [Abstract][Full Text] [Related]
4. Endocannabinoids. Mechoulam R; Fride E; Di Marzo V Eur J Pharmacol; 1998 Oct; 359(1):1-18. PubMed ID: 9831287 [TBL] [Abstract][Full Text] [Related]
5. Cannabinoids and the gut: new developments and emerging concepts. Izzo AA; Sharkey KA Pharmacol Ther; 2010 Apr; 126(1):21-38. PubMed ID: 20117132 [TBL] [Abstract][Full Text] [Related]
6. The Endocannabinoid System and its Modulation by Phytocannabinoids. Di Marzo V; Piscitelli F Neurotherapeutics; 2015 Oct; 12(4):692-8. PubMed ID: 26271952 [TBL] [Abstract][Full Text] [Related]
7. Beyond THC and Endocannabinoids. Pacher P; Kogan NM; Mechoulam R Annu Rev Pharmacol Toxicol; 2020 Jan; 60():637-659. PubMed ID: 31580774 [TBL] [Abstract][Full Text] [Related]
8. Discovery of endocannabinoids and some random thoughts on their possible roles in neuroprotection and aggression. Mechoulam R Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):93-9. PubMed ID: 12052029 [TBL] [Abstract][Full Text] [Related]
9. Cannabimimetic fatty acid derivatives: the anandamide family and other endocannabinoids. Di Marzo V; Bisogno T; De Petrocellis L; Melck D; Martin BR Curr Med Chem; 1999 Aug; 6(8):721-44. PubMed ID: 10469888 [TBL] [Abstract][Full Text] [Related]
11. Cannabinoids. Grotenhermen F Curr Drug Targets CNS Neurol Disord; 2005 Oct; 4(5):507-30. PubMed ID: 16266285 [TBL] [Abstract][Full Text] [Related]
12. Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications. Snider NT; Walker VJ; Hollenberg PF Pharmacol Rev; 2010 Mar; 62(1):136-54. PubMed ID: 20133390 [TBL] [Abstract][Full Text] [Related]
13. The endocannabinoid system: physiology and pharmacology. Rodríguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444 [TBL] [Abstract][Full Text] [Related]
14. New Pyridone-Based Derivatives as Cannabinoid Receptor Type 2 Agonists. Faúndez-Parraguez M; Alarcón-Miranda C; Cho YH; Pessoa-Mahana H; Gallardo-Garrido C; Chung H; Faúndez M; Pessoa-Mahana D Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681877 [TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory lipids in plants: plant fatty acid amides and the human endocannabinoid system. Gertsch J Planta Med; 2008 May; 74(6):638-50. PubMed ID: 18275004 [TBL] [Abstract][Full Text] [Related]
16. Innovative Therapeutic Potential of Cannabinoid Receptors as Targets in Alzheimer's Disease and Less Well-Known Diseases. Páez JA; Campillo NE Curr Med Chem; 2019; 26(18):3300-3340. PubMed ID: 29484980 [TBL] [Abstract][Full Text] [Related]
17. Endogenous cannabinoids revisited: a biochemistry perspective. Fonseca BM; Costa MA; Almada M; Correia-da-Silva G; Teixeira NA Prostaglandins Other Lipid Mediat; 2013; 102-103():13-30. PubMed ID: 23474290 [TBL] [Abstract][Full Text] [Related]
18. Psychopharmacology of the endocannabinoids: far beyond anandamide. Pamplona FA; Takahashi RN J Psychopharmacol; 2012 Jan; 26(1):7-22. PubMed ID: 21652605 [TBL] [Abstract][Full Text] [Related]
19. CB receptor ligands from plants. Woelkart K; Salo-Ahen OM; Bauer R Curr Top Med Chem; 2008; 8(3):173-86. PubMed ID: 18289087 [TBL] [Abstract][Full Text] [Related]
20. An Introduction to the Endogenous Cannabinoid System. Lu HC; Mackie K Biol Psychiatry; 2016 Apr; 79(7):516-25. PubMed ID: 26698193 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]